Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it ...

Sanjay Konagurthu, PhD, senior director of Science and Innovation at Thermo Fisher Scientific, spoke with PharmTech at AAPS ...

PharmTech spoke with Pauric Bannigan, chief scientific officer and co-founder, Intrepid Labs, at AAPS PharmSci 360 2026, ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.

On October 27, 2026, Humanitas Global Health announced its launch at the American Association of Pharmaceutical Scientists’ (AAPS) PharmSci 360 event, which is being held in New Orleans from October ...

Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with ...

This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ...

In this interview with PharmTech, at AAPS PharmSci 360, Johnson discusses her presentation, “Platform Formulations as Tools for Risk Redistribution and Accelerated Development,” which draws on two ...

FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up ...

OpenAI acquired Orchestra Bio to pair AI agents that track drug development timelines with its Rosalind life sciences tools, ...

FDA grants ravulizumab accelerated approval in IgA nephropathy after a 43.4% proteinuria cut, signaling new IV biologic ...

The FDA’s Rare Disease Framework Initiative brings risk-based CMC review and pre-approval inspections into scope for sponsors ...